Michael Renard
First SEC filing: March 14, 2013 · Latest: March 14, 2013
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 4, 2015 | VIVS | A | 130,000 | · | · | 130,000 Direct | · | Acquired | (price as of 2026-10-05) |
| May 8, 2014 | VIVS | M | 50,000 | · | · | 500,000 Direct | -9.09% | Disposed | (price as of 2026-10-05) |
| May 8, 2014 | VIVS | M | 50,000 | $1.65 | $82,500 | 50,000 Direct | · | Acquired | -99.9% (price as of 2026-10-05) |
| Feb. 21, 2014 | VIVS | M | 10,000 | · | · | 550,000 Direct | -1.79% | Disposed | (price as of 2026-10-05) |
| Feb. 21, 2014 | VIVS | S 10b5-1 | 10,000 | $10.65 | $106,500 | 0 Direct | -100.00% | Disposed | -100.0% (price as of 2026-10-05) |
| Feb. 21, 2014 | VIVS | M | 10,000 | $1.65 | $16,500 | 10,000 Direct | · | Acquired | -99.9% (price as of 2026-10-05) |
| Feb. 19, 2014 | VIVS | A | 155,000 | · | · | 155,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 29, 2014 | VIVS | M | 30,000 | · | · | 560,000 Direct | -5.08% | Disposed | (price as of 2026-10-05) |
| Jan. 29, 2014 | VIVS | S 10b5-1 | 30,000 | $9.93 | $297,900 | 0 Direct | -100.00% | Disposed | -100.0% (price as of 2026-10-05) |
| Jan. 29, 2014 | VIVS | M | 30,000 | $1.65 | $49,500 | 30,000 Direct | · | Acquired | -99.9% (price as of 2026-10-05) |
| Jan. 27, 2014 | VIVS | M | 10,000 | · | · | 590,000 Direct | -1.67% | Disposed | (price as of 2026-10-05) |
| Jan. 27, 2014 | VIVS | S 10b5-1 | 10,000 | $8.92 | $89,200 | 0 Direct | -100.00% | Disposed | -100.0% (price as of 2026-10-05) |
| Jan. 27, 2014 | VIVS | M | 10,000 | $1.65 | $16,500 | 10,000 Direct | · | Acquired | -99.9% (price as of 2026-10-05) |
| March 12, 2013 | VIVS | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-05) |
| July 23, 2012 | VIVS | A | 600,000 | · | · | 600,000 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 4, 2015 | VIVS | Stock Option (Right to Buy) [F1] | Common Stock | $4.92 | June 4, 2025 | 130,000 | Acquired |
| May 8, 2014 | VIVS | Stock Option (Right to Buy) | Common Stock | $1.65 | July 23, 2022 | 50,000 | Disposed |
| Feb. 21, 2014 | VIVS | Stock Option (Right to Buy) | Common Stock | $1.65 | July 23, 2022 | 10,000 | Disposed |
| Feb. 19, 2014 | VIVS | Stock Option (Right to Buy) [F2] | Common Stock | $9.86 | Feb. 19, 2024 | 155,000 | Acquired |
| Jan. 29, 2014 | VIVS | Stock Option (Right to Buy) | Common Stock | $1.65 | July 23, 2022 | 30,000 | Disposed |
| Jan. 27, 2014 | VIVS | Stock Option (Right to Buy) | Common Stock | $1.65 | July 23, 2022 | 10,000 | Disposed |
| March 12, 2013 | VIVS | Stock Option (Right to Buy) | Common Stock | $3.93 | March 12, 2023 | 100,000 | Acquired |
| July 23, 2012 | VIVS | Stock Option (Right to Buy) | Common Stock | $1.65 | July 23, 2022 | 600,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2016 | $180,118 | · | · | · | $56,875 | · | · | $980,704 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.